Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,140 | 3 | 99.1% |
| Education | $54.97 | 2 | 0.6% |
| Food and Beverage | $32.39 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $9,140 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.93 | 1 | $0 (2018) |
| Genentech USA, Inc. | $25.04 | 1 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $20.18 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $12.21 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $12.21 | 1 | E.R. Squibb & Sons, L.L.C. ($12.21) |
| 2019 | $6,860 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($6,860) |
| 2018 | $2,335 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($2,280) |
| 2017 | $20.18 | 1 | Sunovion Pharmaceuticals Inc. ($20.18) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/15/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Cardiovascular | ||||||
| 09/13/2019 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered (Drug) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| 05/10/2019 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered (Drug) | Consulting Fee | Cash or cash equivalent | $4,560.00 | General |
| 10/26/2018 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $2,280.00 | General |
| 08/08/2018 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $29.93 | General |
| 02/05/2018 | Genentech USA, Inc. | HEMLIBRA (Biological) | Education | In-kind items and services | $25.04 | General |
| Category: Hematology | ||||||
| 08/28/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 91 | 131 | $19,593 | $6,145 |
| 2020 | 3 | 168 | 299 | $48,496 | $13,052 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 39 | $6,162 | $1,594 | 25.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 24 | 30 | $3,150 | $1,341 | 42.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 18 | $4,230 | $1,274 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 27 | $4,266 | $1,228 | 28.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 17 | $1,785 | $708.37 | 39.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 39 | 104 | $16,432 | $3,869 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 26 | 48 | $11,280 | $3,009 | 26.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 54 | $8,532 | $2,096 | 24.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 27 | 41 | $4,224 | $1,685 | 39.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 31 | $3,093 | $1,282 | 41.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 21 | $4,935 | $1,111 | 22.5% |
About Dr. Thomas Coyle, MD
Dr. Thomas Coyle, MD is a Hematology & Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821026774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Coyle, MD has received a total of $9,227 in payments from pharmaceutical and medical device companies, with $12.21 received in 2020. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($9,140).
As a Medicare-enrolled provider, Coyle has provided services to 259 Medicare beneficiaries, totaling 430 services with total Medicare billing of $19,197. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Cincinnati, OH
- Active Since 06/29/2006
- Last Updated 03/04/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1821026774
Products in Payments
- Non-Covered (Drug) $6,860
- Non-Covered $2,280
- HEMLIBRA (Biological) $25.04
- UTIBRON (Drug) $20.18
- ELIQUIS (Drug) $12.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cincinnati
Dr. David Waterhouse, Md, MD
Hematology & Oncology — Payments: $1.3M
Dr. Elyse Lower, Md, MD
Hematology & Oncology — Payments: $386,700
Dr. Alexander Starodub, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $254,325
Dr. James Essell, Md, MD
Hematology & Oncology — Payments: $223,019
Davendra Sohal, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $124,378
Dr. Edward Faber, D.o., M.s, D.O., M.S
Hematology & Oncology — Payments: $116,895